JAHA:社会隔离会增加心衰患者死亡风险!

2018-05-27 MedSci MedSci原创

感知型社会隔离对人体的健康有不良的影响。本研究的目的旨在评估心衰患者的感知型社会隔离对预后的影响。本研究纳入了2013年至2015年诊断的3867名心衰患者,对其感知型社会隔离程度进行了回顾评估,其中有2003名患者对问卷进行了反馈(反馈率52%),1681名患者(男性占53%,平均年龄为73岁)回答了所有的问题,并作为本次研究的对象。分析结果显示,有312名(19%)患者有中度的感知型社会隔离,

感知型社会隔离对人体的健康有不良的影响。本研究的目的旨在评估心衰患者的感知型社会隔离对预后的影响。

本研究纳入了2013年至2015年诊断的3867名心衰患者,对其感知型社会隔离程度进行了回顾评估,其中有2003名患者对问卷进行了反馈(反馈率52%),1681名患者(男性占53%,平均年龄为73岁)回答了所有的问题,并作为本次研究的对象。分析结果显示,有312名(19%)患者有中度的感知型社会隔离,108名(6%)患者有重度感知型社会隔离。与轻度或无感知型社会隔离的患者相比,有中度的感知型社会隔离患者的死亡、住院和急诊风险并没有增高,然而,有重度感知型社会隔离患者的死亡风险增高了3.5倍以上(HR:3.74; 95% [CI], 1.82-7.70),住院风险增加了68%(HR:1.68; 95% CI, 1.18-2.39),急诊风险增加了57%(HR:1.57; 95% CI, 1.09-2.27)。

研究结果显示,感知型社会隔离程度越高的心衰患者的死亡风险越高,预后更差。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1983585, encodeId=b6e71983585f0, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun May 05 15:15:00 CST 2019, time=2019-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255767, encodeId=b4371255e67bb, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue May 29 10:15:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267829, encodeId=0def126e829cc, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Tue May 29 10:15:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373411, encodeId=718913e3411b6, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue May 29 10:15:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616866, encodeId=2a711616866a7, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Tue May 29 10:15:00 CST 2018, time=2018-05-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1983585, encodeId=b6e71983585f0, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun May 05 15:15:00 CST 2019, time=2019-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255767, encodeId=b4371255e67bb, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue May 29 10:15:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267829, encodeId=0def126e829cc, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Tue May 29 10:15:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373411, encodeId=718913e3411b6, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue May 29 10:15:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616866, encodeId=2a711616866a7, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Tue May 29 10:15:00 CST 2018, time=2018-05-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1983585, encodeId=b6e71983585f0, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun May 05 15:15:00 CST 2019, time=2019-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255767, encodeId=b4371255e67bb, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue May 29 10:15:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267829, encodeId=0def126e829cc, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Tue May 29 10:15:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373411, encodeId=718913e3411b6, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue May 29 10:15:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616866, encodeId=2a711616866a7, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Tue May 29 10:15:00 CST 2018, time=2018-05-29, status=1, ipAttribution=)]
    2018-05-29 zhaohui6731
  4. [GetPortalCommentsPageByObjectIdResponse(id=1983585, encodeId=b6e71983585f0, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun May 05 15:15:00 CST 2019, time=2019-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255767, encodeId=b4371255e67bb, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue May 29 10:15:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267829, encodeId=0def126e829cc, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Tue May 29 10:15:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373411, encodeId=718913e3411b6, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue May 29 10:15:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616866, encodeId=2a711616866a7, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Tue May 29 10:15:00 CST 2018, time=2018-05-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1983585, encodeId=b6e71983585f0, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun May 05 15:15:00 CST 2019, time=2019-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255767, encodeId=b4371255e67bb, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue May 29 10:15:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267829, encodeId=0def126e829cc, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Tue May 29 10:15:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373411, encodeId=718913e3411b6, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue May 29 10:15:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616866, encodeId=2a711616866a7, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Tue May 29 10:15:00 CST 2018, time=2018-05-29, status=1, ipAttribution=)]

相关资讯

JAHA:电生理手术对患者的辐射暴露问题不容忽视!

本研究的目的旨在大样本病人数据中评估电生理或器械植入术中X线暴露的情况和比较不同技术的房颤消融术对患者的X线暴露情况。本研究纳入了6095例接受电生理检查的患者和2055例器械植入的患者,经过7年时间的分析评估,发现电生理检查的X线暴露量、剂量面积乘积与有效剂量呈逐年下降趋势(p<0.001),通过分析2416例房颤消融术,发现7名不同的有经验的操作者在X线暴露量、剂量面积乘积与有效剂量方面存在明

JAHA:PCI术后血栓形成风险高的患者出血风险也会高

经皮冠脉介入术后的血栓和出血风险的评估对于指导抗血栓治疗至关重要。本研究纳入了CREDO‐Kyoto数据库中的4778名患者,并在RESET与NEXT数据库中的4669名患者中进行重复确认,主要血栓形成和出血事件为心梗、支架血栓或缺血性卒中。在预测血栓形成的评分中,慢性肾脏疾病、房颤、外周血管疾病和贫血为2分,年龄≥75岁、心衰、糖尿病和慢性完全闭塞为1分,在预测出血事件的评分中,血小板减少症、严

JACC:心脏病女性孕期的并发症发病率依旧较高

本研究的目的旨在评估患有心脏疾病的女性在孕期的并发症,并估算出风险分层指数。本研究纳入了1938例患有心脏疾病的孕妇,发现有16%的患者在孕期出现有心脏并发症,其中主要包括心律失常和心衰,虽然孕期的心脏并发症发生率近些年来无明显变化,但肺水肿的发生率呈逐年下降趋势。分析结果发现了可以预测心脏并发症发生的10个因素:包括5个一般因素(原发性心血管事件或心律失常、较差的心功能分级、高危的瓣膜疾病或左室

JACC:智能手表心律记录软件有助于房颤的筛查

卡迪拉带(KB)是苹果手表中的一种可以记录患者心率和心律的技术,本研究的目的旨在评估KB能否准确辨别房颤患者的窦性心律(SR)。本研究纳入了100例房颤患者(年龄68 ± 11岁),在其进行复律之前接受了12导联心电图检查和KB记录,如果患者进行了复律治疗,则对其复律后的心电图和KB进行了记录,并对KB分析结果和12导联心电图结果进行了对比。最终,有8例患者没有进行复律治疗,共有169例同时进行的

JACC:IL-1β抑制剂不能降低糖尿病的发病风险

由白介素(IL)-1β介导的亚临床炎症参与了外周胰岛素抵抗的形成,本研究的目的旨在评估IL-1β抑制剂卡纳单抗能否减少糖尿病的发生。本研究纳入了10061名原发性心梗和高敏C反应蛋白(hsCRP)≥2 mg/l的患者,将其随机分成安慰剂组和卡纳单抗组,其中,有4057名患者在入组前就有糖尿病,4960名患者有糖尿病前期,仅1044名患者血糖水平是正常的。经过平均3.7年时间的随访,在入组前无糖尿病

JACC:大样本研究显示先心病外科术后远期死亡率仍居高不下

先天性心脏病外科手术治疗能明显提高复杂先心病的生存率,但其远期的预后效果尚未阐明。本研究纳入了美国儿童心脏病数据库中的35998名接受了首次先心病外科手术治疗且存活下来的年龄小于21岁的患者,经过平均18年时间的随访,有3191名患者出现了死亡,标准化死亡率(SMR)为8.3(95% [CI]: 8.0 - 8.7),15年的SMR从早期的12.7(1982-1992)下降至晚期的10(1998-